CorMedix Profit Margin

The latest profit margin for CRMD is 103.89% as of March 2026. That compares with -23.92% in the prior-year period — up 534.4% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside CorMedix's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRMD's profit margin moved from -23.92% to 103.89% — a 534.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CorMedix's valuation or profitability profile.

Against Healthcare companies, CRMD currently prints 103.89% for profit margin, while the sector average sits near 15.29%. That is roughly 579.3% above the sector mean. Large gaps often invite a closer look at CorMedix's growth, margins, and balance sheet.

Profit Margin shows how effectively CorMedix converts resources into returns. At 103.89%, CRMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -23.92% in the prior-year period — up 534.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CRMD's profit margin (103.89%), review year-over-year change from -23.92%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.